tirzepatide surpass cvot Diabetes Distilled: SURPASS-CVOT – demonstrates cardiovascular benefit in secondary prevention 💡 New insight in diabetes

Mounjaro has shown potential for greater weight loss in certain studies, but Ozempic has also been approved to lower the risk of stroke and heart failure in addition to treating Type 2 diabetes

, Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, N

Focus on balanced mealsthe goal is fueling at the right level, not continuing to reduce

Were talking irritability and sadness that can hit you like a freight train

We provide the full spectrum of care-from initial medical assessment and lab review to prescription management and ongoing virtual follow-ups-all through a secure online platform

Studies from Japan have found that these side effects are more frequent with semaglutide compared to medications like sitagliptin [22]